Augmentation of post transplant immunity: Antigen encounter at the time of hematopoietic stem cell transplantation enhances antigen-specific donor T-cell responses in the post transplant repertoire

Bone Marrow Transplantation

Volumn 35, Issue 8, 2005, Pages 793-801

  Mori, S ^a   Kocak, U ^b   Shaw, J L ^c   Mullen, Craig A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hematopoietic stem cell transplantation; Immunity; T cell; Vaccination

Indexed keywords

ANTIGEN; INFLUENZA VACCINE; OVALBUMIN; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; LYMPHOCYTE TRANSFUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINATION;

ANIMALS; ANTIGENS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; GRAFT VS HOST DISEASE; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES; SPLEEN; SUCCINIMIDES; T-LYMPHOCYTES; TIME FACTORS;

EID: 18144413563     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704883     Document Type: Article

References (23)

1. Mackall CL, Granger L, Sheard MA et al. T cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived vs thymic-independent progeny. Blood 1993; 82: 2585-2594.
2. Avigan D, Pirofski LA, Lazarus HM. Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7: 171-183.
3. Sprent J, Tough DF, Sun S. Factors controlling the turnover of T memory cells. Immunol Rev 1997; 156: 79-85.
4. Marrack P, Mitchell T, Bender J et al. T cell survival. Immunol Rev 1998; 165: 279-285.
5. Gray D, Matzinger P. T cell memory is short-lived in the absence of antigen. J Exp Med 1991; 174: 969-974.
6. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 1994; 179: 317-321.
7. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T cell memory without antigen. Nature 1994; 369: 648-652.
8. Sprent J. Immunological memory. Curr Opin Immunol 1997; 9: 371-379.
9. Kundig TM, Bachmann MF, Ohashi PS et al. On T cell memory: Arguments for antigen dependence. Immunol Rev 1996; 150: 63-90.
10. Anderson LJ, Petropoulos D, Everse LA, Mullen CA. Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res 1999; 59: 1525-1530.
11. Anderson LD, Savary CA, Mullen CA. Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease. Blood 2000; 95: 2426-2433.
12. + T cell memory determined by clonal burst size. Nature 1994; 369: 652-654.
13. Lausen BF, Hougs L, Schejbel L et al. Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient. J Immunol 2004; 172: 3305-3318.
14. Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000; 96: 2299-2303.
15. Ljungman P, Wiklundhammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone-marrow transplantation. J Infect Dis 1990; 162: 496-500.
16. Engelhard D, Handsher R, Naparstek E et al. Immune-response to polio vaccination in bone-marrow transplant recipients. Bone Marrow Transplantat 1991; 8: 295-300.
17. Oehen S, Waldner H, Kündig TM et al. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 1992; 176: 1273-1281.
18. Anderson LD, Mori S, Mann S et al. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease. Cancer Res 2000; 60: 5797-5802.
19. Redman RL, Nader S, Zerboni L et al. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 1997; 176: 578-585.
20. Davis TA, Hsu FJ, Caspar CB et al. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma. Biol Blood Marrow Transplant 2001; 7: 517-522.
21. Zoller M. Tumor vaccination after allogeneic bone marrow cell reconstitution of the nonmyeloablatively conditioned tumor-bearing murine host. J Immunol 2003; 171: 6941-6953.
22. Borrello I, Sotomayor EM, Rattis FM et al. Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood 2000; 95: 3011-3019.
23. Ochsenbein AF, Klenerman P, Karrer U et al. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA 1999; 96: 2233-2238.